6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18415032 | Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four | REGA, KYLE THOMAS | 1636 | Final Rejection | Jan 17, 2024 |
| 18132278 | Polynucleotides, Compositions, and Methods for Genome Editing | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Final Rejection | Apr 07, 2023 |
| 18050333 | Methods of in Vitro Cell Delivery | ZHU, JIANJIAN | 1631 | Non-Final OA | Oct 27, 2022 |
| 17897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | NGUYEN, QUANG | 1631 | Final Rejection | Aug 29, 2022 |
| 17836265 | Modified Guide RNAs for Gene Editing | ARIETI, RUTH SOPHIA | 1635 | Non-Final OA | Jun 09, 2022 |
| 17111769 | Modified Guide RNAs for Gene Editing | PENNINGTON, KATIE LEIGH | 1634 | Final Rejection | Dec 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial